In this randomized controlled trial in participants with episodic migraine, taking an eicosapentaenoic acid supplement reduced migraine frequency and severity, compared with taking a placebo.
This Study Summary was published on September 2, 2024.
In this randomized controlled trial in participants with episodic migraine, taking an eicosapentaenoic acid supplement reduced migraine frequency and severity, compared with taking a placebo.
This Study Summary was published on September 2, 2024.
